As companies report their earnings for the latest quarter, they’ve fielded question after question from analysts about how ...
Mizuho cut Intra-Cellular Therapies, Inc. ITCI price target from $140 to $132. Mizuho analyst Graig Suvannavejh downgraded the stock from Outperform to Neutral. Intra-Cellular Therapies shares closed ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ICL Group Ltd’s ICL shares have rallied 31% in the past three months, significantly outperforming the Zacks Fertilizers ...
Companies in the Materials sector have received a lot of coverage today as analysts weigh in on Nutrien (NTR – Research Report), Mercer ...
Nutrien offers value with an attractive yield, improved Q4 performance, and bullish technical signals. Read why I have a buy rating on NTR stock.
Nutrien (NYSE:NTR – Free Report) had its price target increased by Wells Fargo & Company from $53.00 to $56.00 in a research ...
Wells Fargo analyst Richard Garchitorena maintained a Buy rating on Cf Industries Holdings (CF – Research Report) on February 21 and set a ...